Trade deficit with India decreased in 2017, concerned over trade barriers: US Ruby Khatun Khatun6 April 2018 9:45 AM ISTThe trade deficit between India and the US dropped by almost six percent in 2017 compared to the previous year, the US Trade Representative (USTR) has...
Eli Lilly Cyramza succeeds in late-stage liver cancer trial Ruby Khatun Khatun6 April 2018 9:30 AM ISTEli Lilly and Co’s cancer drug Cyramza helped patients with liver cancer live longer, meeting the main goal of a late-stage trial, four years after...
Suven Life gets product patent from Canada Ruby Khatun Khatun5 April 2018 10:45 AM ISTNew Delhi: Suven Life Sciences said that it has been granted a product patent by Canada corresponding to New Chemical Entities (NCEs) for the...
Pharma may see recovery with FY19 profit set to jump 20-22 percent: Crisil Ruby Khatun Khatun5 April 2018 10:15 AM ISTNew Delhi: After a bruising two years, the domestic pharmaceutical sector is set for a sharp turnaround in the new fiscal year with a 20-22 percent...
GE Healthcare to sell IT unit to Veritas for 1.05 billion Ruby Khatun Khatun5 April 2018 9:45 AM ISTGeneral Electric Co's healthcare unit said it would sell its information technology business to private equity firm Veritas Capital for $1.05 billion...
Pfizer in deal with Allogene to develop cancer cell therapies Ruby Khatun Khatun5 April 2018 9:30 AM ISTPfizer Inc said it would take a 25 percent stake in Allogene Therapeutics to accelerate the development of CAR T cell therapies sourced from donors...
Dr Reddy's, Promius Pharma file NDA for migraine candidate Ruby Khatun Khatun4 April 2018 10:30 AM ISTHyderabad: Dr Reddy's Laboratories Ltd and its subsidiary, Promius Pharma, LLC announced the filing of New Drug Application (NDA) for its migraine...
Substandard and falsified medical products may cause harm to patients Ruby Khatun Khatun4 April 2018 10:15 AM ISTKolkata: Substandard and falsified medical products may cause harm to patients and fail to treat the diseases for which they were intended.Falsified...
European Medicines Agency to review Sanofi-Regeneron's Dupixent, Cemiplimab Ruby Khatun Khatun4 April 2018 9:45 AM ISTPARIS: The European Medicines Agency (EMA) will review the Dupixent (dupilumab) and Cemiplimab products being developed by drugmakers Sanofi and...
Allergan weighs options for women's health unit: Report Ruby Khatun Khatun4 April 2018 9:30 AM ISTAllergan Plc, which has been looking for ways to counter its stock slump as new threats to its top-selling skin and eye drugs have emerged, is...
Strides Shasun gets USFDA approval for generic Ibuprofen capsules Ruby Khatun Khatun3 April 2018 10:30 AM ISTNew Delhi: Drug firm Strides Shasun said it has received approval from the US health regulator for generic Ibuprofen capsules, 200 mg, used for...
Lupin gets Health Canada clearance for Pithampur unit Ruby Khatun Khatun3 April 2018 10:15 AM ISTNew Delhi: Drug firm Lupin Ltd said its Pithampur unit 2 manufacturing facility located in Indore has been cleared by Health Canada after a...
